References
- 1
van Sandick J W, van Lanschot J J, Kuiken B W. et al .
Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage
and clinical outcome of Barrett’s carcinoma.
Gut.
1998;
43
216-222
- 2
Haggitt R C.
Barrett’s esophagus, dysplasia, and adenocarcinoma.
Human Pathol.
1994;
25
982-993
- 3
Reid B J, Levine D S, Longton G. et al .
Predictors of progression to cancer in Barrett’s esophagus: baseline histology and
flow cytometry identify low- and high-risk patient subsets.
Am J Gastroenterol.
2000;
95
1669-1676
- 4
Odze R D.
Diagnosis and grading of dysplasia in Barrett’s oesophagus.
J Clin Pathol.
2006;
59
1029-1038
- 5
Reid B J, Haggitt R C, Rubin C E. et al .
Observer variation in the diagnosis of dysplasia in Barrett’s esophagus.
Human Pathol.
1988;
19
166-178
- 6
Montgomery E, Bronner M P, Goldblum J R. et al .
Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.
Human Pathol.
2001;
32
368-378
- 7
Alikhan M, Rex D, Khan A. et al .
Variable pathologic interpretation of columnar-lined esophagus by general pathologists
in community practice.
Gastrointest Endosc.
1999;
50
23-26
- 8
Baak J P, ten Kate F J, Offerhaus G J. et al .
Routine morphometrical analysis can improve reproducibility of dysplasia grade in
Barrett’s oesophagus surveillance biopsies.
J Clin Pathol.
2002;
55
910-916
- 9
Skacel M, Petras R E, Gramlich T L. et al .
The diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for
disease progression.
Am J Gastroenterol.
2000;
95
3383-3387
- 10
Montgomery E, Goldblum J R, Greenson J K. et al .
Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up
study based on 138 cases from a diagnostic variability study.
Human Pathol.
2001;
32
379-388
- 11
Schnell T G, Sontag S J, Chejfec G. et al .
Long-term nonsurgical management of Barrett’s esophagus with high-grade dysplasia.
Gastroenterology.
2001;
120
1607-1619
- 12
Weston A P, Banerjee S K, Sharma P. et al .
p53 protein overexpression in low-grade dysplasia (LGD) in Barrett’s esophagus: immunohistochemical
marker predictive of progression.
Am J Gastroenterol.
2001;
96
1355-1362
- 13
Conio M, Blanchi S, Lapertosa G. et al .
Long-term endoscopic surveillance of patients with Barrett’s esophagus. Incidence
of dysplasia and adenocarcinoma: a prospective study.
Am J Gastroenterol.
2003;
98
1931-1939
- 14
Dulai G S, Shekelle P G, Jensen D M. et al .
Dysplasia and risk of further neoplastic progression in a regional Veterans Administration
Barrett’s cohort.
Am J Gastroenterol.
2005;
100
775-783
- 15
Sharma P, Falk G W, Weston A P. et al .
Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus.
Clin Gastroenterol Hepatol.
2006;
4
566-572
- 16
Srivastava A, Hornick J L, Li X. et al .
Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma
in Barrett’s esophagus.
Am J Gastroenterol.
2007;
102
483-493; quiz, 694
- 17
Lim C H, Treanor D, Dixon M F, Axon A TR.
Low-grade dysplasia in Barrett’s esophagus has a high risk of progression.
Endoscopy.
2007;
39
581-587
- 18
Shaheen N J, Crosby M A, Bozymski E M, Sandler R S.
Is there publication bias in the reporting of cancer risk in Barrett’s esophagus?.
Gastroenterology.
2000;
119
333-338
- 19
Ofman J J, Lewin K, Ramers C. et al .
The economic impact of the diagnosis of dysplasia in Barrett’s esophagus.
Am J Gastroenterol.
2000;
95
2946-2952
- 20
Shaheen N J.
Should we worry about the length of Barrett’s esophagus?.
Gastrointest Endosc.
2005;
62
682-685
- 21
Sharma P.
Low-grade dysplasia in Barrett’s esophagus.
Gastroenterology.
2004;
127
1233-1238
- 22
Dorer R, Odze R D.
AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett’s esophagus,
ulcerative colitis, and Crohn’s disease.
Am J Surg Pathol.
2006;
30
871-877
- 23
Buttar N S, Wang K K, Sebo T J. et al .
Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma.
Gastroenterology.
2001;
120
1630-1639
- 24
Skacel M, Petras R E, Rybicki L A. et al .
p53 expression in low-grade dysplasia in Barrett’s esophagus: correlation with interobserver
agreement and disease progression.
Am J Gastroenterol.
2002;
97
2508-2513
- 25
Kara M A, Peters F P, Rosmolen W D. et al .
High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett’s
esophagus: a prospective randomized crossover study.
Endoscopy.
2005;
37
929-936
- 26
Sharma P, Bansal A, Mathur S. et al .
The utility of a novel narrow-band imaging endoscopy system in patients with Barrett’s
esophagus.
Gastrointest Endosc.
2006;
64
167-175
- 27
Kara M A, Peters F P, Fockens P. et al .
Endoscopic video-autofluorescence imaging followed by narrow-band imaging for detecting
early neoplasia in Barrett’s esophagus.
Gastrointest Endosc.
2006;
64
176-185
- 28
Kiesslich R, Gossner L, Goetz M. et al .
In vivo histology of Barrett’s esophagus and associated neoplasia by confocal laser
endomicroscopy.
Clin Gastroenterol Hepatol.
2006;
4
979-987
Prateek Sharma, MD
Department of Gastroenterology (111)
Veterans Affairs Medical Center
4801 E. Linwood Blvd.
Kansas City
Missouri 64128-2295
USA
Fax: +1-816-922-4692
Email: psharma@kumc.edu
